| Literature DB >> 34067417 |
Xia Yan1, Han Ouyang2, Wei Wang3, Jing Liu1, Te Li1, Bin Wu4, Xiaojun Yan1, Shan He1.
Abstract
Chemical investigation of the South China Sea soft coral Lemnalia sp. afforded 13 structurally diverse terpenoids, including three new neolemnane sesquiterpene lineolemnene, E-G (1-3); a new aristolane-type sesquiterpenoid, 2-acetoxy-aristolane (4); four new decalin-type bicyclic diterpenes, named biofloranate A-D (5-8); a new serrulatane, named euplexaurene D (9); and a new aromadendrane-type diterpenoid cneorubin K (10), together with three known related compounds (11-13). The structures of the new compounds were elucidated by NMR spectroscopy, the Mosher's method, and ECD analysis. Compounds 1-13 were tested in a wide panel of biological assays. Lineolemnene J (3) showed weak cytotoxicity against the CCRF-CEM cancer cell line. The isolated new diterpenes, except euplexaurene D (9), demonstrated moderate antimicrobial activity against Bacillus subtilis and Staphylococcus aureus with a MIC of 4-64 μg/mL. Compound 2 exhibited a mild inhibitory effect against influenza A H1N1 virus (IC50 = 5.9 µM).Entities:
Keywords: Lemnalia sp.; antimicrobial activity; cytotoxicity; soft coral; terpenoids
Mesh:
Substances:
Year: 2021 PMID: 34067417 PMCID: PMC8224568 DOI: 10.3390/md19060294
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–13.
NMR spectroscopic data (1H 600 MHz, 13C 150 MHz, CDCl3) for compounds 1–4.
| 1 | 2 | 3 | 4 | |||||
|---|---|---|---|---|---|---|---|---|
| Position | ||||||||
| 1 | 5.43, m | 123.4, CH | 5.49, m | 125.1, CH | 5.46, m | 123.9, CH | 5.17, br.s | 118.1, CH |
| 2a | 2.07, m | 26.1, CH2 | 2.09, m | 26.0, CH2 | 2.06, m | 26.0, CH2 | 5.35, m | 68.9, CH |
| 2b | 2.01, m | — | 2.09, m | — | 2.06, m | — | — | — |
| 3a | 1.49, m | 26.6, CH2 | 1.51, m | 26.1, CH2 | 1.48, m | 26.7, CH2 | 1.93, m | 42.6, CH2 |
| 3b | 1.37, m | — | 1.51, m | — | 1.41, m | — | 1.57, m | — |
| 4 | 2.26, ov | 36.0, CH | 2.41, m | 33.2, CH | 2.28, m | 35.3, CH | 1.95, m | 37.9, CH |
| 5 | — | 46.2, C | — | 45.3, C | — | 43.6, C | — | 51.7, C |
| 6 | 5.82, s | 138.6, CH | 5.22, s | 147.5, CH | 5.33, s | 132.4, CH | 0.85, d (6.5) | 38.8, CH |
| 7 | — | 127.8, C | — | 128.0, C | — | 137.4, C | 1.22, br.t (6.3) | 32.4, CH |
| 8a | 5.66, s | 85.5, CH | 5.16, s | 84.8, CH | 5.67, d (6.9) | 73.7, CH | 2.01, m | 26.8, CH2 |
| 8b | — | — | — | — | — | — | 1.74, m | — |
| 9a | — | 201.2, C | — | 203.2, C | 4.86, dd (9.9, 7.3) | 79.5, CH | 1.90, m | 33.0, CH2 |
| 9b | — | — | — | — | — | — | 1.59, m | — |
| 10a | 2.75, td (12.6, 3.8) | 40.8, CH2 | 2.38, m | 42.9, CH2 | 1.74, m | 32.2, CH2 | — | 145.9, C |
| 10b | 2.16, m | — | 2.08, m | — | 1.57, dd (15.1, 9.3) | — | — | — |
| 11a | 2.59, m | 32.6, CH2 | 2.33, m | 34.3, CH2 | 2.22, dd (15.2, 9.4) | 34.6, CH2 | — | 20.3, C |
| 11b | 2.30, ov | — | 2.32, m | — | 2.05, m | — | — | — |
| 12 | — | 140.4, C | — | 142.4, C | — | 143.8, C | 1.00, s | 28.8, CH3 |
| 13 | 1.51, s | 13.0, CH3 | 2.01, s | 21.2, CH3 | 1.72, s | 15.5, CH3 | 1.14, s | 17.1, CH3 |
| 14 | 1.13, s | 21.4, CH3 | 1.03, s | 21.0, CH3 | 1.05, s | 22.1, CH3 | 1.76, s | 20.4, CH3 |
| 15 | 0.99, d (6.9) | 17.8, CH3 | 0.95, d (6.9) | 17.5, CH3 | 0.91, d (6.9) | 17.6, CH3 | 1.07, d (7.1) | 17.0, CH3 |
| 7-OAc | — | — | — | — | — | — | — | 171.1, C |
| — | — | — | — | — | — | 2.04, s | 21.5, CH3 | |
| 8-OAc | — | 170.1, C | — | 170.6, C | — | 170.1, C | — | — |
| 2.18, s | 20.8, CH3 | 2.23, s | 20.9, CH3 | 2.01, s | 20.9, CH3 | — | — | |
| 9-OAc | — | — | — | — | — | 169.8, C | — | — |
| — | — | — | — | 2.12, s | 20.9, CH3 | — | — | |
ov Overlapped signals, — absence of value.
Figure 2Key 1H-1H COSY and HMBC correlations of 1–10.
Figure 3Key NOESY correlations of 1–4 and 9–10.
Figure 4Experimental and calculated ECD spectra of compounds 1 and 2.
1H NMR (600 MHz) spectroscopic data for compounds 5–10.
| Position | 5 | 6 | 7 | 8 | 9 | 10 |
|---|---|---|---|---|---|---|
| 1a | 1.85, m | 1.84, m | 1.78, m | 1.84, ov | 1.84, m | 1.88, ov |
| 1b | 1.36, ov | 1.36, m | 1.36, ov | 1.37, ov | 1.52, ov | 1.47, qd (11.5, 8.3) |
| 2a | 1.98, ov | 1.97, m | 1.99, ov | 1.98, ov | 1.53, ov | 2.40, m |
| 2b | 1.92, ov | 1.91, ov | 1.95, ov | 1.91, ov | 1.35, ov | 2.31, m |
| 4 | 5.47, br.s | 5.47, br.s | 5.45, br.s | 5.48, br.s | 0.87, ov | 1.71, ov |
| 5 | 2.04, dd (9.3, 4.7) | 2.02, m | 2.04, ov | 2.04, m | 0.80, ov | 0.54, br.t (9.5) |
| 6 | 1.52, ov | 1.48, m | 1.51, dt (7.4, 3.1) | 1.51, m | 1.14, m | 0.66, td (10.9, 10.1, 6.5) |
| 7a | 1.78, ov | 1.75, ov | 1.83, ov | 1.84, ov | 1.33, ov | 1.85, ov |
| 7b | 1.78, ov | 1.75, ov | 1.78, ov | 1.77, ov | 0.83, ov | 0.89, m |
| 8a | 5.39, br.s | 5.39, br.s | 5.39, br.s | 5.40, br.s | 1.57, ov | 1.75, dd (12.9, 7.1) |
| 8b | — | — | — | — | 0.51, m | 1.60, ov |
| 9 | — | — | — | — | 1.64, dd (11.9, 6.0) | — |
| 10 | 1.95, ov | 1.93, ov | 1.94, ov | 1.94, ov | — | 1.92, td (11.1, 6.5) |
| 11 | 1.78, ov | 1.78, ov | 1.83, ov | 1.79, ov | 1.51, ov | — |
| 12a | 1.38, ov | 1.18, ov | 1.36, ov | 1.30, ov | 1.46, m | 1.26, m |
| 12b | 1.22, ov | 1.18, ov | 1.36, ov | 1.21, ov | 1.21, m | 1.16, m |
| 13a | 1.51, m | 1.69, ov | 2.27, m | 1.19, m | 2.04, dd (13.9, 6.3) | 2.06, m |
| 13b | 1.36, ov | 1.62, ov | 2.27, m | 1.19, m | 1.92, dq (14.5, 7.5) | 2.06, m |
| 14a | 3.85, dd (8.0, 3.8) | 1.39, ov | 6.88, t (7.8) | 1.37, ov | 5.12, br.t (6.2) | 5.09, t (7.1) |
| 14b | — | 1.15, m | — | 1.08, ov | — | — |
| 15 | 2.54, qd (7.2, 3.5) | — | — | 1.61, m | — | — |
| 16a | — | — | — | 3.40, dd (10.4, 6.6) | 1.61, s | 1.60, s |
| 16b | — | — | — | 3.49, dd (10.5, 5.9) | — | — |
| 17 | 1.18, d (7.2) | 1.39, s | 4.33, br.s | 0.90, d (6.7) | 1.69, s | 1.67, s |
| 18 | 0.83, d (6.8) | 0.79, d (6.7) | 0.84, d (6.9) | 0.81, d (6.8) | 0.90, d (6.7) | 1.04, s |
| 19a | 1.68, s | 1.69, s | 1.70, s | 1.69, s | 1.28, s | 4.90, s |
| 19b | — | — | — | — | — | 4,79, s |
| 20 | 1.68, s | 1.68, s | 1.69, s | 1.69, s | 0.93, d (6.4) | 1.12, s |
| OMe | 3.71, s | 3.78, s | 3.78, s | — | — | — |
ov Overlapped signals, — absence of value.
13C NMR (150 MHz) spectroscopic data for compounds 5–10.
| Position | 5 | 6 | 7 | 8 | 9 | 10 |
|---|---|---|---|---|---|---|
| 1 | 24.6, CH2 | 24.6, CH2 | 24.5, CH2 | 24.7, CH2 | 29.5, CH2 | 26.3, CH2 |
| 2 | 30.8, CH2 | 30.8, CH2 | 30.7, CH2 | 30.8, CH2 | 36.3, CH2 | 32.1, CH2 |
| 3 | 134.7, C | 134.6, C | 134.8, C | 134.5, C | 80.4, C | 157.8, C |
| 4 | 123.6, CH | 123.8, CH | 123.4, CH | 123.8, CH | 39.0, CH | 41.6, CH |
| 5 | 36.3, CH | 36.4, CH | 36.2, CH | 36.3, CH | 23.1, CH | 32.7, CH |
| 6 | 39.1, CH | 38.9, CH | 38.7, CH | 39.0, CH | 42.5, CH | 26.6, CH |
| 7 | 24.6, CH2 | 24.6, CH2 | 24.5, CH2 | 24.6, CH2 | 25.3, CH2 | 20.4, CH2 |
| 8 | 121.2, CH | 121.4, CH | 121.0, CH | 121.4, CH | 31.7, CH2 | 44.6, CH2 |
| 9 | 136.7, C | 136.7, C | 136.6, C | 136.6, C | 30.9, CH | 75.1, C |
| 10 | 39.5, CH | 39.6, CH | 39.4, CH | 39.5, CH | 33.6, C | 57.9, CH |
| 11 | 31.8, CH | 35.6, CH | 31.6, CH | 31.7, CH | 38.3, CH | 23.2, C |
| 12 | 31.4, CH2 | 31.6, CH2 | 34.5, CH2 | 35.9, CH2 | 34.6, CH2 | 43.2, CH2 |
| 13 | 31.9, CH2 | 21.7, CH2 | 26.6, CH2 | 25.0, CH2 | 26.1, CH2 | 25.4, CH2 |
| 14 | 72.1, CH | 40.6, CH2 | 146.1, CH | 33.5, CH2 | 125.0, CH | 124.8, CH |
| 15 | 44.0, CH | 74.8, C | 130.4, C | 35.8, CH | 131.3, C | 131.1, C |
| 16 | 176.7, C | 177.9, C | 168.0, C | 68.4, CH2 | 17.7, CH3 | 17.6, CH3 |
| 17 | 10.6, CH3 | 26.0, CH3 | 57.2, CH2 | 16.6, CH3 | 25.7, CH3 | 25.7, CH3 |
| 18 | 13.2, CH3 | 13.3, CH3 | 13.1, CH3 | 13.3, CH3 | 16.1, CH3 | 13.7, CH3 |
| 19 | 23.9, CH3 | 24.0, CH3 | 23.8, CH3 | 24.0, CH3 | 27.9, CH3 | 105.5, CH2 |
| 20 | 21.7, CH3 | 21.8, CH3 | 21.6, CH3 | 21.7, CH3 | 18.8, CH3 | 20.5, CH3 |
| OMe | 51.7, CH3 | 52.7, CH3 | 51.7, CH3 |
Figure 5ΔδH values (Δδ (in ppm) = δS-δR) obtained for (S)- and (R)-MTPA esters of compound 5 in pyridine-d5.
Scheme 1Plausible biosynthetic pathway of diterpenoids 5–13.